RYTM
Rhythm Pharmaceuticals Inc
98.70$
+0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 95.2% | 90.6% | 99.3% | 99.4% | 98.0% | 97.1% | 93.6% | 92.6% | 92.6% | 95.4% | 97.2% | |
| 78.4% | 93.5% | 53.0% | 22.6% | 19.0% | 20.2% | 53.9% | 18.0% | 33.4% | 18.1% | 22.7% | 11.3% | |
| 78.4% | 93.5% | 85.4% | 97.6% | 96.9% | 94.8% | 92.4% | 89.5% | 87.1% | 82.9% | 81.7% | 81.0% | |
| – | – | – | – | – | – | 0.0% | 0.3% | 1.6% | 4.5% | 4.7% | 5.4% | |
| – | – | – | 0.0% | – | – | – | 0.0% | 0.8% | 2.6% | 4.8% | 5.4% | |
| – | 0.0% | 7.5% | 0.6% | 0.4% | 1.9% | 1.7% | 0.9% | 0.6% | – | – | – | |
| – | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | 0.0% | – | – | – | 1.4% | 2.1% | 2.1% | 1.6% | 1.1% | |
| 284.5% | 14.1% | 40.9% | 4.6% | 5.4% | 8.9% | 11.0% | 13.8% | 30.9% | 49.0% | 58.1% | 43.8% | |
| 284.5% | 14.1% | 38.3% | 4.4% | 5.2% | 7.9% | 9.6% | 13.2% | 10.4% | 16.6% | 29.4% | 22.1% | |
| – | 9.5% | – | – | – | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.4% | 0.1% | |
| 275.8% | 3.8% | 15.4% | 1.6% | 2.9% | 3.4% | 2.6% | 1.7% | 1.3% | 1.5% | 3.1% | 2.9% | |
| – | – | – | 0.0% | – | – | – | – | 0.4% | – | – | – | |
| -184.5% | 85.9% | 59.1% | 95.4% | 94.6% | 91.1% | 89.0% | 86.2% | 69.1% | 51.0% | 41.9% | 56.2% | |
| -20,411.3% | -135.9% | -620.3% | -72.7% | -70.9% | -105.4% | -245.5% | -160.5% | -185.6% | -268.9% | -294.5% | -281.5% | |
| 5,255.8% | 27.4% | 135.6% | 17.6% | 11.9% | 11.8% | 23.6% | 15.1% | 13.6% | 17.3% | 15.5% | 13.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.